Discover 489 paid clinical trials in Providence, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 489
I-DECIDE After Bronchiolitis Hospitalization
for
Bronchiolitis Acute
Location: Providence RI, Boston MA, Springfield MA, Hartford CT,
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0 - 2
Code: NCT07243652
Recruiting
Augmented Reality-Cardiopulmonary Resuscitation Support for Pediatric Resuscitation
Location: Providence RI, New York NY, Baltimore MD, Toronto,
Sponsor: International Spine Study Group Foundation
Sex: All
Age: 18+
Code: NCT04194138
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease
for
Fibrostenotic Crohn's Disease
Location: Providence RI, Albany NY, Bradenton FL, Fort Worth TX,
Sponsor: Agomab Spain S.L.U.
Sex: All
Age: 18+
Code: NCT07683325
Phase 2, Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn Disease
Location: Providence RI, Carmel NY, New York NY, Philadelphia PA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07196722
Phase 2, Phase 3, Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for
Ulcerative Colitis, Obesity or Overweight
Location: Providence RI, New Bedford MA, Lebanon NH, Yonkers NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937086
Phase 3, Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
for
Crohn's Disease, Obesity or Overweight
Location: Providence RI, New Bedford MA, Lebanon NH, Yonkers NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937099
Phase 3, Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission